Synthesis and biological studies of neutral technetium (V) complexes containing NNOS donor sets

Complexation of ligands containing an N₃S donor set has been affected with [^99mTc]. These are part of a ligand series of analogous structures which exhibit similar chemistry and potentially interesting biology. The complexes which have been characterized with [^33mTc]as [TcOL] are neutral and lipophilic and their biological behaviour has been assessed in rats. After HPLC purification of the no-carrier added preparation, brain uptake of the tracers was > 1% at 15 min p.i. Muscle activity was significant with slow blood clearance.     

Synthesis,characterization, and biological evaluation of technetium(III) complexes with tridentate/bidentate S,E,S/P,S coordination (E = O,N(CH(3)), S): a novel approach to robust technetium chelates suitable for linking the metal to biomolecules

A novel type of mixed-ligand Tc(III) complexes, [Tc(SCH(2)CH(2)-E-CH(2)CH(2)S)(PR(2)S)] (E = S, N(CH(3)); PR(2)S = phosphinothiolate with R = aryl, alkyl) is described. These "3+2"-coordinated complexes can be prepared in a two-step reduction/substitution procedure via the appropriate chloro-containing oxotechnetium(V) complex [TcO(SES)Cl] [E=S, N(CH(3)]. Tc(III) compounds have been fully characterized both in solid and solution states and found to adopt the trigonal-bipyramidal coordination geometry. The equatorial trigonal plane is formed by three thiolate sulfur atoms, whereas the phosphorus of the bidentate P,S ligand and the neutral donor of the tridentate chelator occupy the apical positions. The (99)Tc(III) complexes have been proven to be identical with the (99m)Tc agents prepared at the no-carrier-added level by comparison of the corresponding UV/vis and radiometric HPLC profiles. Challenge experiments with glutathione clearly indicate that this tripeptide has no effect on the stability of the (99m)Tc complexes in solutions. Biodistribution studies have been carried out in rats at 5 and 120 min postinjection. The substituents at the bidentate P,S ligand significantly influence the biodistribution pattern. Remarkable differences are observed especially in brain, blood, lungs, and liver. All the complexes are able to penetrate the blood-brain barrier of rats and showed a relatively fast washout from the brain.     

Synthesis and biological evaluation of two novel DAT-binding technetium complexes containing a piperidine based analogue of cocaine

Two new technetium complexes containing a piperidine template have been synthesized and evaluated as possible leads for the development of dopamine transporter (DAT) imaging agents. Binding data for the corresponding rhenium complexes containing either a monoaminomonoamide (MAMA') or a diaminodithiol (DADT) chelating unit exhibited significant affinity for the DAT. Initial biodistribution studies in rats revealed only a low brain uptake.     

Synthesis, structural characterization and biological studies of novel mixed ligand Ag(I) complexes with triphenylphosphine and aspirin or salicylic acid

Two new mixed ligand silver(I) complexes of formulae {[Ag(tpp)₃(asp)](dmf)} (1) (aspH = o-acetylsalicylic acid and tpp = triphenylphosphine) and [Ag(tpp)₂(o-Hbza)] (2) (o-HbzaH = o-hydroxy-benzoic acid) were synthesized and characterized by elemental analyses, spectroscopic techniques and X-ray crystallography at ambient conditions. Three phosphorus and one carboxylic oxygen atoms from a de-protonated aspirin ligand in complex 1 and two phosphorus and two carboxylic oxygen atoms from a chelating o-Hbza anion in complex 2 form a tetrahedral geometry around Ag(I) ions in both complexes.Complexes 1 and 2 and the silver(I) nitrate, tpp, aspNa and o-HbzaH were tested for their in vitro cytotoxic activity against leiomyosarcoma cells (LMS), human breast adenocarcinoma cells (MCF-7) and normal human fetal lung fibroblasts (MRC-5) cells with Thiazolyl Blue Tetrazolium Bromide (MTT) assay. For both cell lines 1 and 2 were found to be more active than cisplatin. Additionally, 1 and 2 exhibit lower activity on cell growth proliferation of MRC-5 cells. The type of LMS cell death caused by 1 and 2 were evaluated in vitro by use of flow cytometry assay. The results show that at concentrations of 1.5 and 1.9 μΜ of complex 1, 44.1% and 69.4%, respectively of LMS cells undergo programmed cell death (apoptosis). When LMS cells were treated with 1.6 and 2.3 μM of 2, LMS cells death was by 29.6% and 81.3%, respectively apoptotic. Finally, the influence of the complexes 1 and 2, upon the catalytic peroxidation of linoleic acid to hydroperoxylinoleic acid by the enzyme lipoxygenase (LOX) was kinetically and theoretically studied. The binding of 1 and 2 towards LOX was also investigated by Saturation Transfer Difference (STD) ¹H NMR experiments.     

Synthesis and reactivity of osmium (VI) nitrido complexes containing pyridine-carboxylato ligands

A series of osmium(VI) nitrido complexes containing pyridine-carboxylato ligands Os^VI(N)(L)₂X (L = pyridine-2carboxylate (1), 2-quinaldinate (2) and X = Cl (a), Br (1b and 2c) or CH₃O (2b)) and [Os^VI(N)(L)X₃]⁻ (L = pyridine-2,6-dicarboxylate (3) and X = Cl (a) or Br (b)) have been synthesised. Complexes 1 and 2 are electrophilic and react readily with various nucleophiles such as phosphine, sulfide and azide. Reaction of Os^VI(N)(L)₂X (1 and 2) with triphenylphosphine produces the osmium(IV) phosphiniminato complexes Os^VI(NPPh₃)(L)₂X (4 and 5). The kinetics of nitrogen atom transfer from the complexes Os^VI(N)(L)₂Br (2c) (L = 2-quinaldinate) with triphenylphosphine have been studied in CH₃CN at 25.0 °C by stopped-flow spectrophotometric method. The following rate law is obtained: −d[Os(VI)]/dt = k₂[Os(VI)][PPh₃]. Os^VI(N)(L)₂Cl (L = 2-quinaldinate) (2a) reacts also with [PPN](N₃) to give an osmium(III) dichloro complex, trans-[PPN][Os^III(L)₂Cl₂] (6). Reaction of Os^VI(N)(L)₂Cl (L = 2-quinaldinate) (2a) with lithium sulfide produces an osmium(II) thionitrosyl complex Os^II(NS)(L)₂Cl (7). These complexes have been structurally characterised by X-ray crystallography.     

Synthesis, characterization and biological studies of organotin(IV) complexes with hydrazone ligand

Four organotin(IV) complexes with general formula [RSnCl_n−1(TCB)] [R = Ph₂, n = 2 (2); R = Me, n = 3 (3); R = Bu, n = 3 (4); R = Ph, n = 3 (5)] have been synthesized by direct reaction of thiophene-2-carboxaldehyde benzhydrazone ligand [HTCB, (1)], base and organotin(IV) chloride in absolute methanol under N₂ atmosphere. All organotin(IV) complexes were characterized by elemental analyses, molar conductivity, UV-Vis, FT-IR, ¹H and ¹³C NMR spectral studies. Among them, diphenyltin(IV) complex (2) has also been characterized by X-ray crystallography diffraction analyses. The cytotoxicity of the hydrazone ligand as well as its organotin(IV) complexes (2-5) were determined with Artemia salina. While no-choice bioassay was employed on Coptotermes sp. to evaluate the termiticidal effect of all the complexes. Besides, the ligand (1) and its organotin(IV) complexes (2-4) were also tested against five types of bacteria namely Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Salmonella typhi.     

Synthesis, characterization and DNA binding of ruthenium(II) complexes containing the atatp ligand

Acenaphtheno[1,2-b]-1,4,8,9-tetraazatriphenylene (atatp) and its complexes [Ru(L)2atatp](ClO4)2 x nH2O (L = 2,2'-bipyridine (bpy), n=2 (1); 1,10-phenanthroline (phen), n=2 (2); and 2,9-dimethyl-1,10-phenanthroline (dmp), n=1 (3)) have been synthesized and characterized by elemental analyses and 1H NMR. The spectral and electrochemical properties of these complexes are also examined. Complexes 1 and 2 display bright luminescence in acetonitrile but very weak luminescence in water solution. However, complex 3 is not luminescent in either solvent. The interaction of the complexes with calf thymus DNA (CT-DNA) has been studied by absorption, emission and viscosity measurements. The intrinsic binding constants of complexes 1 and 2 are 7.6 x 10(4) and 8.8 x 10(4) M(-1) respectively. The relatively low affinities of complexes 1 and 2 with DNA may arise from the atatp ligand, indicating that the size and shape of the intercalated ligand have a marked effect on the strength of interaction. Complexes 1 and 2 bind with CT-DNA in an intercalative mode but complex 3 in a non-intercalative one, showing that changing the ancillary ligand affects not only the binding magnitude, but also the binding mode of the interaction.     

Synthesis of oxorhenium(V) and oxotechnetium(V) [SN(R)S/S] mixed ligand complexes containing a phenothiazine moiety on the tridentate SN(R)S ligand.

Two oxorhenium and two oxotechnetium [SN(R)S/S] mixed ligand complexes bearing the phenothiazine moiety on the tridentate ligand SN(R)S have been synthesized and characterized. The corresponding complexes at tracer level (99mTc) have also been prepared.     

1,10-Phenanthroline-dithiolate mixed ligand transition metal complexes. Synthesis, characterization and EPR spectroscopy

A series of new N₂S₂ mixed ligand transition metal complexes, where N₂ is phenanthroline and S₂ is 1,2-dithiooxalate (dto) or 1,2-dithiosquarate (dtsq), has been synthesized and characterized. IR spectra reveal that the 1,2-dithiolate ligands are coordinated via the sulfur atoms forming a N₂S₂ coordination sphere. The copper(II) complex [Cu(phen)(dto)] was studied by EPR spectroscopy as a diamagnetically diluted powder. The diamagnetic dilution resulted from doping of the copper complex into the isostructural host lattice of the nickel complex [Ni(phen)(dto)]. The electronic situation in the frontier orbitals of the copper complex calculated from the experimental data is compared to the results of EHT and DFT calculations. Furthermore, one side product, chlorobis(1,10-phenanthroline)copper(I) ethanol solvate hydrate [(phen)₂CuCl]·C₂H₅OH·H₂O, was formed by a reduction process and characterized by X-ray diffraction. In the crystal packing one-dimensional columns of dimers are formed, stabilized by significant π-π interactions.     

Ruthenium(II) carbonyl complexes containing S-methylisothiosemicarbazone based tetradentate ligand: synthesis, characterization and biological applications

A series of hexa-coordinated ruthenium(II) complexes of the type [Ru(CO)(B)L ⁿ ] (n = 1–4; B = PPh₃, AsPh₃ or Py) have been synthesized by reacting dibasic quadridentate Schiff base ligands H₂L ⁿ (n = 1–4) with starting complexes [RuHCl(CO)(EPh₃)₂(B)] (E = P or As; B = PPh₃, AsPh₃ or Py). The synthesized complexes were characterized using elemental and various spectral studies including UV–Vis, FT-IR, NMR (¹H, ¹³C and ³¹P) and mass spectroscopy. An octahedral geometry was tentatively proposed for all the complexes based on the spectral data obtained. The experiments on antioxidant activity showed that the ruthenium(II) S-methylisothiosemicarbazone Schiff base complexes exhibited good scavenging activity against various free radicals (DPPH, OH and NO). The in vitro cytotoxicity of these complexes has been evaluated by MTT assay. The results demonstrate that the complexes have good anticancer activities against selected cancer cell line, human breast cancer cell line (MCF-7) and human skin carcinoma cell line (A431). The DNA cleavage studies showed that the complexes have better cleavage of pBR 322 DNA.     

Synthesis, characterization and DNA binding studies of two mixed ligand complexes of ruthenium(II)

Two mixed ligand complexes [Ru(bpy)(2)(DMHBT)]Cl(2)(1) and [Ru(phen)(2)(DMHBT)]Cl(2) (2) (where DMHBT is 11,13-dimethyl-13H-4,5,9,11,14-hexaaza-benzo[b]triphenylene-10,12-dione) have been synthesized and characterized by electrospray ionization (ESI) mass, (1)H-(1)H correlation spectroscopy (COSY), electronic spectroscopy, fluorescence spectroscopy and cyclic voltammetry. Spectroscopic titration and viscosity changes of calf thymus (CT)-DNA in the presence of incremental amount of complexes 1 and 2 clearly demonstrate that both these complexes bind intercalatively to DNA, with binding constant 2.87+/-0.20 x 10(4)M(-1) and 1.01+/-0.20 x 10(5)M(-1) for complexes 1 and 2, respectively. All the experimental evidences suggest that the ancillary ligand 2,2'-bipyridine (bpy) and 1,10-phenanthroline (phen) influences the intercalative binding of these complexes to DNA.     

Synthesis and characterization of complexes containing the bis(1, 2-diolato)-oxotechnetium(V) core

The complexes (Bu₄N)[TcO(O₂C₆H₄)₂] (1) and Na[TcO(OCH₂CH₂O)₂] (2) have been prepared by reacting TcOCl₄^- with respective diols in methanol. Compound 2 was identified by its elemental analysis and field desorption mass spectrum. Crystals of compound 1 are monoclinic, C2/c, with cell dimensions a = 10.393(3), b = 13.835(3), c = 20.643(5) Å, β = 101.74(3)° and four formula units in the unit cell. The crystal structure was determined by standard methods and refined to R₁ = 0.0694, R₂ = 0.0613, on the basis of 2887 independent reflections. The data were collected with use of Mo Kα radiation and a Syntex P2₁ diffractometer. The anion of 1 is square pyramidal with a short TcO(oxo) bond (1.648(5) Å). TcO distances to the diolate groups are longer (1.956(3), 1.958(3) Å). The technetium atom lies 0.7014(4) Å out of the plane of the four diolate oxygen atoms. Compound 2 is hydrolytically unstable in pure water, but can be stabilized by the addition of a several-fold molar excess of ethylene glycol. Compound 1 decomposes minimally in pure water after 24 h. These complexes are shown to be good structural models for ^99mTc-radiopharmaceuticals containing purely oxygen-donor ligands. Comparison of the physical properties of the structurally characterized members of the series of complexes with core structures TcOS_xO_(4-x) (x = O, 2, 4) shows a shift to low energy in the frequency of the terminal oxygen-technetium band in the IR correlated with increasing softness of the basal plane donor atom set.     

A novel ternary ligand system useful for preparation of cationic (99m)Tc-diazenido complexes and (99m)Tc-labeling of small biomolecules

This report describes a novel ternary ligand system composed of a phenylhydrazine, a crown ether-containing dithiocarbamate (DTC), and a PNP-type bisphosphine (PNP). The combination of three different ligands with (99m)Tc results in cationic (99m)Tc-diazenido complexes, [(99m)Tc(NNAr)(DTC)(PNP)]+, with potential radiopharmaceuticals for heart imaging. Synthesis of cationic (99m)Tc-diazenido complexes can be accomplished in two steps. For example, the reaction of phenylhydrazine with (99m)TcO4- at 100 degrees C in the presence of excess stannous chloride and 1,2-diaminopropane-N,N,N',N'-tetraacetic acid (PDTA) results in the [(99m)Tc(NNPh)(PDTA)n] intermediate, which then reacts with sodium N-(dithiocarbamato)-2-aminomethyl-15-Crown-5 (L4) and N,N-bis[2-(bis(3-ethoxypropyl)phosphino)ethyl]ethoxyethylamine (PNP6) at 100 degrees C for 15 min to give the complex, [(99m)Tc(NNPh)(L4)(PNP6)]+ in high yield (>90%). Cationic complexes [(99m)Tc(NNPh)(DTC)(PNP)]+ are stable for > or = 6 h. Their composition was determined to be 1:1:1:1 for Tc:NNPh:DTC:PNP using the mixed-ligand experiments on the tracer ((99m)Tc) level and was further confirmed by the ESI-MS spectral data of a model compound [Re(NNPh)(L4)(L6)]+. It was found that both DTCs and bisphosphines have a significant impact on the lipophilicity of their cationic (99m)Tc-diazenido complexes. Results from a (99m)Tc-labeling efficiency experiment showed that 4-hydrazinobenzoic acid (HYBA) might be useful as a bifunctional coupling agent for (99m)Tc-labeling of small biomolecules. However, the (99m)Tc-labeling efficiency of HYBA is much lower than that of 6-hydrazinonicotinic acid (HYNIC) with tricine and trisodium triphenylphosphine-3,3',3'-trisulfonate (TPPTS) as coligands.     

Synthesis,biological characterization and evaluation of molecular mechanisms of novel copper complexes as anticancer agents

BackgroundTo overcome the hurdles of cisplatin, majorly its toxicity and resistance, there has been extensive search for alternative anti-cancer metal-based compounds. Here, three Cu(II)-complexes, Cu(Sal-Gly)(phen), Cu(Sal-Gly)(pheamine), Cu(Sal-Gly)(phepoxy) are characterized for their interaction with DNA, cytotoxicity and mechanism of action.MethodsThe binding ability of the complexes to Calf-Thymus DNA was evaluated by competition fluorescence studies with thiazole-orange, UV–Vis and circular dichroism spectroscopic titrations. Cytotoxicity was evaluated by MTT analysis. The DNA damage was analyzed through cleavage of supercoiled DNA via agarose gel-electrophoresis, and 8-oxo-guanidine and ɣH2AX staining in cells. Apoptosis was detected via DNA condensation/fragmentation, mitochondrial membrane potential, Annexin V staining and caspase 3/7 activity. Formation of reactive oxygen species was determined by DCFDA- and GSSG/GSH-analysis.ResultsBinding constants to DNA were evaluated as 1.7 × 10⁶ (Cu(Sal-Gly)(phen)), 2.5 × 10⁶ (Cu(Sal-Gly)(pheamine)) and 3.2 × 10⁵ (Cu(Sal-Gly)(phepoxy)). All compounds induced DNA damage. Apoptosis was the main form of cell death. There was an increase in ROS, which is most likely responsible for the observed DNA-damage. Although the compounds were cytotoxic to all tested cancer cell lines, only Cu(Sal-Gly)(pheamine) displayed significantly lower toxicity towards non-cancer cells, its associated phenotypes differing from the other two Cu-complexes. Thus, Cu(Sal-Gly)(pheamine) was further assayed for molecular changes in response to drug treatment using a custom designed RT-qPCR array. Results showed that Harakiri was significantly upregulated. Presence of p53 was not required for apoptosis in response to Cu-complexes.Conclusions and general significanceThese Cu-complexes, namely Cu(Sal-Gly)(pheamine), may be considered promising anticancer agents with activity in cancer cells even with deficient p53 status.     

Synthesis and characterization of Cu(II) and Ni(II) complexes of a tripodal ligand containing imidazoles

Two complexes of the formula [MH₃L](ClO₄)₂ [M = Cu(II) (1), Ni(II) (2)] have been prepared by the reaction of M(ClO₄)₂ · 6H₂O with the ligand (H₃L) formed by the Schiff base condensation of tris(2-aminoethyl)amine (tren) with three molar equivalents of 4-methyl-5-imidazolecarboxaldehyde and structurally and magnetically characterized. The structures of 1 and 2 are isomorphous with each other and with the iron(II) complex of H₃L which has been reported previously. The ligand, while potentially heptadentate, forms six coordinate complexes with both metal centers forming three M-N_imine and three M-N_imidazole bonds. The tren central N atom is at a nonbonded distance from M of 3.261 Å for 1 and 3.329 Å for 2. The neutral complex CuHL 3 was prepared by reaction of H₃L with Cu(OCH₃)₂ and the ionic complex Na[NiL] 4 was prepared by deprotonation of 2 with aqueous sodium hydroxide. Magnetic measurements of 1-3 are consistent with the spin-only values expected for S = 1/2 (d⁹, Cu(II)) and S = 1 (d⁸, Ni (II)) systems.     

Synthesis, characterization of some organolanthanide complexes containing 2-pyridylmethyl substituted fluorenyl ligand and catalytic activity of organolanthanide(II) complexes

A series of organolanthanide complexes with 2-pyridylmethyl substituted fluorenyl ligand were synthesized via reaction of [(Me₃Si)₂N]₃Ln^III(μ-Cl)Li(THF)₃ (Ln = Yb, Eu, Nd, Y) with the functionalized fluorene compound. Treatment of [(Me₃Si)₂N]₃Ln^III(μ-Cl)Li(THF)₃ (Ln = Yb, Eu) with 2 equiv. of C₅H₄NCH₂C₁₃H₉ (1) at 60-80 °C in toluene afforded the corresponding organolanthanide(II) complexes with formula [η⁵:η¹- C₅H₄NCH₂C₁₃H₈]₂Ln [Ln = Yb (2), Eu (3)] via tandem silylamine elimination/homolysis of the Ln-N bond reaction. Reaction of [(Me₃Si)₂N]₃Ln^III(μ-Cl)Li(THF)₃ (Ln = Y, Nd) with 2 equiv. of C₅H₄NCH₂C₁₃H₉ in toluene at 80 °C produced the corresponding organolanthanide(III) complexes with formula [η⁵:η¹-C₅H₄NCH₂C₁₃H₈]₂LnCl [Ln = Y (4), Nd (5)]. Complexes 4 and 5 could also be prepared by treatment of 2 equiv. of lithium fluorenide [η⁵:η¹-C₅H₄NCH₂C₁₃H₈]Li(THF)₂ (6) with corresponding LnCl₃. All compounds were fully characterized by spectroscopic methods and elemental analyses. The structures of complexes 4 and 6 were additionally determined by single-crystal X-ray analyses. The catalytic properties of the divalent organolanthanide complexes 2 and 3 on the ring-opening polymerization of ε-caprolactone (CL) have been studied. The temperatures, solvents effects on the catalytic activities of the complexes were examined.     

Synthesis, characterization and crystal structure of novel mononuclear peroxotungsten(VI) complexes. Insulinomimetic activity of W(VI) and Nb(V) peroxo complexes

Two new mononuclear peroxo complexes of tungsten of the formula (gu)₂[WO₂(O₂)₂] (1) and (gu)[WO(O₂)₂(quin-2-c)] (2a) (where gu⁺ = guanidinium ion, and quin-2-c = quinoline-2-carboxylate ion) have been synthesized and characterized by elemental analysis, infrared, Raman, UV-visible and ¹H NMR spectroscopies. The crystal structure of (gu)[WO(O₂)₂(quin-2-c)] · H₂O (2b) determined by X-ray diffraction indicates that the side-on peroxo groups and the bidentate quinaldate ligand bind the W(VI) centre leading to an hepta coordination mode. The guanidinium ion occurring as a counterion and the hydrogen-bound interactions stabilize the complexes. The in vitro insulin-mimetic effect of the complexes has been evaluated by the inhibitory effect on free fatty acid release in isolated fat adipocytes treated with epinephrine. Moreover the niobate analogues, synthesized and characterized previously, (gu)₃[Nb(O₂)₄] and (gu)₂[Nb(O₂)₃(quin-2-c)] · H₂O have been tested for the insulin-like activity.     

Synthesis and biological evaluation of a novel 99mTc nitrido radiopharmaceutical with deoxyglucose dithiocarbamate,showing tumor uptake

The deoxyglucose dithiocarbamate (DGDTC) was synthesized and radiolabelled with [^99mTcN]²⁺ intermediate to form the ^99mTcN–DGDTC complex. The radiochemical purity of the ^99mTcN–DGDTC complex was over 90%, as measured by TLC and by HPLC, without any notable decomposition at room temperature over a period of 6 h. The partition coefficient and electrophoresis results indicated that this complex was hydrophilic and neutral. The biodistribution of ^99mTcN–DGDTC in mice bearing S 180 tumor showed that the complex accumulated in the tumor with high uptake and good retention. The tumor/blood and tumor/muscle ratios increased with time and reached 2.32 and 1.68 at 4 h post-injection, suggesting it would be a promising candidate for tumor imaging.     

Synthesis and characterization of technetium(V) complexes with tridentate schiff base ligands. X-ray crystal structure of chloro[N-(2-hydroxyphenyl)salicylideneiminato]oxotechnetium(V)

Five-coordinate technetium(V) complexes of the form TcO(L)Cl where L is one of the two tridentate Schiff base ligands N-(2-oxidophenyl)salicylideneiminate or N-(2-mercaptophenyl)salicylideneiminate have been synthesized and characterized. These neutral complexes precipitate from methanol upon reaction of the Schiff base ligand with TcOCl₄^?. A single crystal X-ray structure determination shows that the chloro [[N-(2-oxidophenyl)salicylideneiminato](2?)-N,O,O′]oxotechnetium(V) complex, [TcO(C₁₃H₉NO₂)Cl], formula weight 362, has a distorted square pyramidal coordination geometry with the oxo ligand in the axial position. The steric requirements of the oxo group cause the Tc atom to be displayed 0.67 Å out of the mean equatorial plane of the other four donor atoms. This complex crystallizes in the monoclinic space group P2₁/a with a = 13.423(6) Å, b = 12.570(5) Å, c = 7.769(3) Å, β = 106.53(5)°, V = 1256.7(9) ų, and Z = 4. The structure has been refined to R = 0.047 for 1775 observed reflections.